XTX202 in Patients With Advanced Solid Tumors

Clinical trial NCT05052268 · COMPLETED

Trial details

NCT number: NCT05052268
Sponsor: Xilio Development, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-01-18
Primary completion: 2025-03-22
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.